Spark Investment Management LLC Alkermes Plc. Transaction History

Spark Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$13.31 - $19.41 $1.3 Million - $1.9 Million	-97,800 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$13.06 - $21.24 $1.12 Million - $1.83 Million	-86,000 Reduced 46.79%	97,800 $1.41 Million
Q3 2019 Nov 12, 2019	SELL	$19.51 - $24.28 $614,565 - $764,820	-31,500 Reduced 14.63%	183,800 $3.59 Million
Q1 2019 May 07, 2019	BUY	$28.4 - $36.49 $2.94 Million - $3.77 Million	103,400 Added 92.4%	215,300 $7.86 Million
Q4 2018 Feb 12, 2019	BUY	$27.94 - $44.61 $2.7 Million - $4.31 Million	96,600 Added 631.37%	111,900 $3.3 Million
Q2 2018 Aug 08, 2018	BUY	$40.56 - $51.36 $620,568 - $785,808	15,300 New	15,300 $629,000
Q4 2017 Feb 12, 2018	SELL	$47.69 - $55.39 $2.33 Million - $2.7 Million	-48,800 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $2.4 Million - $2.66 Million	48,800	48,800 $2.48 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.